DSP Healthcare Fund - Direct Plan - Growth vs Nippon India Pharma Fund-Growth Plan-Bonus Option

Side-by-side comparison of NAV, returns, expense ratio and star rating.

TopFund Analysis

The DSP Healthcare Fund - Direct Plan - Growth appears stronger based on performance metrics, achieving a 1-year return of 18.92% and a 3-year CAGR of 20.63%, compared to Nippon India Pharma Fund-Growth Plan-Bonus Option's 1-year return of 11.76% and 3-year CAGR of 16.54%. However, investors should note that while DSP has a lower expense ratio of 0.75%, Nippon India has a significantly higher AUM of ₹9166 Cr, which may indicate greater market confidence. For investors deciding between these funds, DSP Healthcare Fund offers better returns but with a smaller asset base.

DSP Mutual Fund

DSP Healthcare Fund - Direct Plan - Growth

DSP Mutual Fund

★★★★★

Equity · Sectoral Fund

Nippon India Mutual Fund

Nippon India Pharma Fund-Growth Plan-Bonus Option

Nippon India Mutual Fund

★★★★★

Equity · Sectoral Fund

Metric DSP Healthcare Fund - ... Nippon India Pharma Fu...
NAV ₹52.14 ₹582.42
Star Rating ★★★ ★★
Expense Ratio 0.75% 0.99%
AUM ₹3,750 Cr ₹9,166 Cr
1M Return +6.81% +8.53%
3M Return +1.93% +2.09%
6M Return +15.13% +6.88%
1Y Return +18.92% +11.76%
3Y CAGR +20.63% +16.54%
5Y CAGR +17.0% +13.76%
Risk Level — —
Fund Manager Vinit Sambre Sailesh Raj Bhan